Clinical Trial

Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 20, 2022 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.
Trial Details
NCT Number NCT05658081
Lead Sponsor Jinling Hospital, China
Conditions Crohn Disease, Recurrence
Enrollment 236 participants
Start Date 2022-12-08
Primary Completion 2024-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2022-12-20